Coming EventsSee past events
IDMC Interactive Workshop
What you need to know to serve on them, report on them or receive reports from them
An Independent Data Monitoring Committee (IDMC) is a group of independent experts external to a study assessing the progress and accumulating safety and efficacy data of a clinical study during its course. The committee assesses the risk-benefit balance of the study and makes recommendations concerning the trial’s continuation, modification and/or publication . To date there are not enough qualified experts to sit on these committees and most of the time the roles and responsibilities are poorly understood by those conducting clinical trials. This workshop aims to train clinicians and other clinical trial specialists involved in cancer studies on how to interact with and, ultimately, become a member of independent data monitoring committees. The workshop will provide insights into the functioning, roles and responsibilities of IDMC through interactive discussions and worked real life examples; preparing the next generation of investigators and methodologists for cancer clinical trials.
More information on the course website.
3rd EORTC Cancer Survivorship Summit
Everywhere in Europe the survival rate of cancer has improved. As of today, there are around 10 million European cancer survivors of which more than a third are of working age.
Although not being a death sentence anymore, cancer risks to remain a life sentence preventing survivors to resume normal life. Research shows a higher unemployment rate in cancer survivors as compared to the cancer-free population. Also, individual testimonies illustrate challenges in obtaining health/life insurance, loans and mortgage.
CANCER SURVIVORS SHOULD NOT PAY TWICE!
More information on the conference website.
30th EORTC-NCI-AACR Symposium
Hosted by the European Organisation for Research and Treatment of Cancer (EORTC), the National Cancer Institute (NCI) and the American Association for Cancer Research (AACR), the 2018 Symposium attracts academics, scientists and pharmaceutical industry representatives from across the globe to discuss the latest innovations in drug development, target selection and the impact of new discoveries in molecular biology.